Veracyte Inc logo

VCYT - Veracyte Inc News Story

$47.51 0.6  1.3%

Last Trade - 05/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.30bn
Enterprise Value £2.05bn
Revenue £84.9m
Position in Universe 1764th / 6651

BRIEF-Veracyte Announces Novel Gene Fusion Detection With Afirma Xpression Atlas

Wed 1st April, 2020 1:57pm
April 1 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES NOVEL GENE FUSION DETECTION WITH THE
AFIRMA
XPRESSION ATLAS, WHICH MAY INFORM TARGETED TREATMENT DECISIONS
FOR THYROID CANCER PATIENTS
    * VERACYTE INC - LAUNCHES EXPANDED CONTENT TO DETECT NOVEL
NTRK,
ALK, RET AND BRAF FUSIONS AT TIME OF DIAGNOSIS

Source text for Eikon:  ID:nBw9892f2a 
Further company coverage:  VCYT.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.